Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice

Journal of Neurochemistry

Volumn 83, Issue 4, 2002, Pages 837-845

  Kubota, Yasuhiko ^a   Ito, Chihiro ^a   Sakurai, Eiichi ^b   Sakurai, Eiko ^a   Watanabe, Takehiko ^a   Ohtsu, Hiroshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Behavioral sensitization; GABA; Histamine; Histidine decarboxylase; Methamphetamine; Noradrenaline

Indexed keywords

AMINO ACID; BRAIN MONOAMINE; HISTAMINE; HISTIDINE DECARBOXYLASE; METHAMPHETAMINE; NORADRENALIN; PHOSPHOSERINE;

AMINO ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; GABAERGIC SYSTEM; KNOCKOUT MOUSE; LIGHT DARK CYCLE; LOCOMOTION; MESENCEPHALON; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; WILD TYPE;

3,4-DIHYDROXYPHENYLACETIC ACID; AMINO ACIDS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; HISTAMINE; HISTIDINE DECARBOXYLASE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; MALE; METHAMPHETAMINE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOTOR ACTIVITY; NOREPINEPHRINE; PHOSPHOSERINE; PHOTOPERIOD; SEROTONIN;

ANIMALIA;

EID: 0036846211     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01189.x     Document Type: Article

References (36)

1. Brown R. E., Stevens D. R. and Haas H. L. (2001) The physiology of brain histamine. Prog. Neurobiol. 63, 637-672.
2. Cirelli C. and Tononi G. (1998) Changes in anti-phosphoserine and antiphosphothreonine antibody binding during the sleep-waking cycle and after lesions of the locus coeruleus. Sleep Res. Online 1, 11-18.
3. 3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur. J. Pharmacol. 259, 107-114.
4. Crochet S. and Sakai K. (1999) Effects of microdialysis application of monoamines on the EEG and behavioural states in the cat mesopontine tegmentum. Eur. J. Neurosci. 11, 3738-3752.
5. Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
6. 1 receptors. Proc. Natl Acad. Sci. USA 93, 13316-13320.
7. Ito C., Sato M., Onodera K. and Watanabe T. (1996a) The role of the brain histaminergic neuron system in methamphetamine-induced behavioral sensitization in rats. Ann. NY Acad. Sci. 801, 353-360.
8. Ito C., Onodera K., Sakurai E., Sato M. and Watanabe T. (1996b) The effect of methamphetamine on histamine level and histidine decarboxylase activity in the rat brain. Brain Res. 734, 98-102.
9. Ito C., Onodera K., Sakurai E., Sato M. and Watanabe T. (1996c) Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine. J. Pharmacol. Exp. Ther. 279, 271-276.
10. Ito C., Onodera K., Watanabe T. and Sato M. (1997) Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats. Psychopharmacology (Berl.) 130, 362-367.
11. Itoh Y., Nishibori M., Oishi R. and Saeki K. (1984) Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice. Neurosci. Lett. 48, 305-309.
12. Jones S. R., Gainetdinov R. R., Wightman R. M. and Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986.
13. Joshi V. V., Balsara J. J., Jadhav J. H. and Chandorkar A. G. (1981) Effect of 1-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice. Eur. J. Pharmacol. 69, 499-502.
14. Kohlmeier K. A. and Reiner P. B. (1999) Noradrenaline excites noncholinergic laterodorsal tegmental neurons via two distinct mechanisms. Neuroscience 93, 619-630.
15. McCormick D. A., Pape H. C. and Williamson A. (1991) Actions of norepinephrine in the cerebral cortex and thalamus: Implications for function of the central noradrenergic system. Prog. Brain Res. 88, 293-305.
16. Mochizuki T., Yamatodani A., Okakura K., Horii A., Inagaki N. and Wada H. (1992) Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol. Behav. 51, 391-394.
17. Nagy A., Rossant J., Nagy R., Abramow-Newerly W. and Roder J. C. (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA 90, 8424-8428.
18. Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., Tchougounova E., Hellman L., Gertsenstein M., Hirasawa N., Sakurai E., Buzas E., Kovacs P., Csaba G., Kittel A., Okada M., Hara M., Mar. L., Numayama-Tsuruta K., Ishigaki-Suzuki S., Ohuchi K., Ichikawa A., Falus A., Watanabe T. and Nagy A. (2001) Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 502, 53-56.
19. Onodera K. and Ogura Y. (1982) The effect of intraventricular injection of histamine on behavior in mice and rats. Adv. Biosci. 33, 127-135.
20. Onodera K., Yamatodani A., Watanabe T. and Wada H. (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog. Neurobiol. 42, 685-702.
21. Pierce R. C. and Kalivas P. W. (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev 25, 192-216.
22. Prast H., Heistracher M. and Philippu A. (1993) Modulation by dopamine receptors of the histamine release in the rat hypothalamus. Naunyn Schmiedebergs Arch. Pharmacol. 347, 301-305.
23. Prell G. D. and Green J. P. (1986) Histamine as a neuroregulator. Annu. Rev. Neurosci. 9, 209-254.
24. Robinson T. E. and Becker J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. 396, 157-198.
25. Sakai N., Sakurai E., Onodera K., Asada H., Miura Y. and Watanabe T. (1995) Long-term depletion of brain histamine induced by alpha-fluoromethythistidine increases feeding-associated locomotor activity in mice with a modulation of brain amino acid levels. Behav. Brain. Res. 72, 83-88.
26. Sato M., Numachi Y. and Hamamura T. (1992) Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr. Bull. 18, 115-122.
27. Schlicker E., Fink K., Detzner M. and Gothert M. (1993) Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J. Neural Transm. Gen. Sect. 93, 1-10.
28. Schwartz J. C., Arrang J. M., Garbarg M., Pollard H. and Ruat M. (1991) Histaminergic transmission in the mammalian brain. Physiol. Rev. 71, 1-51.
29. Segal D. S. and Kuczenski R. (1994) Behavioral pharmacology of amphetamine, in: Amphetamine and Its Analogs (Cho A. K. and Segal D. S., eds), pp. 115-150. Academic Press, New York.
30. Seiden L. S., Sabol K. E. and Ricaurte G. A. (1993) Amphetamine: Effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33, 639-677.
31. Snyder S. H. (1973) Amphetamine psychosis: A 'model' schizophrenia mediated by catecholamines. Am. J. Psychiatry 130, 61-67.
32. 3H]GABA release from human astrocytoma U373 MG cells. Eur. J. Pharmacol. 318, 185-192.
33. Subramanian N. and Mulder A. H. (1977) Modulation by histamine of the efflux of radiolabeled catecholamines from rat brain slices. Eur. J. Pharmacol. 43, 143-152.
34. Wagner J., Vitali P., Palfreyman M. G., Zraika M. and Huot S. (1982) Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacefic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J. Neurochem. 38, 1241-1254.
35. Watanabe T. and Wada H., eds. (1991) Histaminergic Neurons: Morphology and Function. CRC Press, Boca Raton, FL.
36. Yamatodani A., Fukuda H., Wada H., Iwaeda T. and Watanabe T. (1985) High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: Cation-exchange chromatography coupled with post-column derivatization fluorometry. J. Chromatogr 344, 115-123.